Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/9/2008 First Published: 1/18/2008


1.		Phase II Diagnostic Study of F-18 16 alpha-Fluoroestradiol Imaging in Predicting Response in Women Receiving First-Line Endocrine Therapy For Hormone Receptor-Positive Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Diagnostic				Active				18 and over				NCI				UWCC-6590 6590, 8052, NCT00602043

Last Modified: 10/22/2007 First Published: 8/6/2006


2.		Early Assessment of Response By Fludeoxyglucose-Positron Emission Tomography in Patients With Hormone Receptor-Positive or HER-2/neu-Positive Breast Cancer Treated With Aromatase Inhibitors or Trastuzumab (Herceptin®)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				NCI				UWCC-UW-6213 UWCC-06-0445-H/D, NCT00362973


3.		Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				Other				BR-1-0093 NCT00358098


4.		Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				Other				05-088 NCT00647790

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute